This webinar was recorded on Tuesday, June 1, 2021. Hepatocellular carcinoma (HCC) is a common malignancy worldwide with high mortality rates when diagnosed at advanced stages. This interactive program with expert panelists will cover a range of topics from HCC screening to treatment of advanced disease. The first half of the program will consist of two debates on thought-provoking topics with emerging data and the second half will feature a mock multi-disciplinary tumor board with case presentations and discussions led by hepatology, transplant and hepatobiliary surgery, as well as oncology.
Recognize the pros and cons of HCC screening
Be aware of emerging data suggesting increased risk of HCC depending on entecavir vs. tenofovir use
Understand the different treatment options currently available for HCC
This course is designed for medical providers and trainees within the specialties of internal medicine, gastroenterology, and oncology.
Method of Participation
You will receive the webinar recording link after completing registration in the confirmation email.